Συγγραφείς:
Tausch, E.
Ljungström, V.
Agathangelidis, A.
Zapatka, M.
Scarfò, L.
Jebaraj, B.M.C.
Yosifov, D.Y.
Müller, A.
Munugalavadla, V.
Degenhardt, J.D.
Ghia, P.
Rosenquist, R.
Stilgenbauer, S.
Λέξεις-κλειδιά:
idelalisib; purine derivative; quinazolinone derivative, drug resistance; genetics; MAPK signaling; mutation; tumor cell line; upregulation, Cell Line, Tumor; Drug Resistance, Neoplasm; MAP Kinase Signaling System; Mutation; Purines; Quinazolinones; Up-Regulation
